Stiefel Laboratories, Inc. has made several staff promotions and organizational changes as part of its integration of operations into one global company following its 2006 acquisition of Connetics Corp.

The company has combined its U.S. sales and marketing teams; created a new global marketing team responsible for marketing the company’s product portfolio and launching the former Connetics products; and strengthened its global medical affairs function, which facilitates collaboration and partnership between marketers and medical professionals at the company.

Charles Stiefel, chief executive officer and chairman of the board of Stiefel Labs, commented, “This is an exciting time for Stiefel Laboratories. The products, technology, and the expertise of employees in Palo Alto at the former Connetics Corp. expand our product portfolio. Our product development pipeline is complemented with potential products that will add depth to our offerings. This new structure and the proven team we have assembled will allow us to leverage global efficiencies, unify sales and marketing strategies, and strengthen the Stiefel Laboratories brand globally.”

To lead this new team, the company has promoted Bill Humphries to the newly created position of chief commercial officer. Mr. Humphries will be responsible for all Stiefel sales, marketing, strategic communications, public relations, and other commercial aspects of the company’s global business.

Richard J. MacKay has been appointed to vice chairman of the board of directors. In his new role, Mr. MacKay will assess the most important issues that face the company in a global context and assist the board and chief executive officer on key projects and relationships. Mr. MacKay, who has been associated with Stiefel Labs and its products for more than 40 years, will retain the title of president, Stiefel Canada, Inc.

Also, Pierre Boucher was promoted to executive vice president, responsible for day-to-day operations and strategic planning for Stiefel Canada; Jim Hartman has been promoted to senior vice president, Stiefel U.S. Rx, where he will be responsible for the day-to-day commercial operations of the U.S. Rx business; Bresly Jaramillo has been promoted to senior vice president for Latin America and the Caribbean (LATAC); Gabriel McGlynn will serve as senior vice president of Eurasia, which now includes the combined EMEA (Europe, the Middle East and Africa) and APAC (Asia Pacific) regions; Dr. Larry Staubach, vice president for global medical affairs, and his team will facilitate the collaboration and partnership between the company’s marketers and medical professionals; Alfonso Ugarte, vice president of global marketing, will lead the team responsible for the globalization of the combined product portfolio; Luis Pena, vice president for global portfolio planning, will be responsible for overseeing and leading the planning of the global new products pipeline; Karen Cavanaugh, vice president of the global steroid responsive dermatoses franchise and new product planning, will lead the development and marketing of the company’s combined steroid responsive dermatoses portfolio and the commercial operations group in the development of new products.